Andreas Bender

Andreas is a life science data analyst who is committed to developing new methods in the field (using AI/ML) and their application, primarily related to chemical biology, drug discovery, and in silico toxicology. He is an Associate Director of Computational ADME and Safety within Clinical Pharmacology and Safety Science at AstraZeneca Cambridge, as well as a Reader in Molecular Informatics at the University of Cambridge, with a successful history of spin-outs. He completed a Ph.D. in Cheminformatics at the University of Cambridge, followed by a postdoctoral stay with Novartis in Cambridge/MA.